Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Is the Uranium Rally Losing Momentum? A Look at VanEck’s Nuclear ETF

Dieter Jaworski by Dieter Jaworski
November 7, 2025
in Commodities, Energy & Oil, ETF
0
VanEck Uranium+Nuclear Energy ETF Stock
0
SHARES
135
VIEWS
Share on FacebookShare on Twitter

The VanEck Uranium and Nuclear Energy ETF is navigating a period of significant volatility. Having delivered an impressive performance with gains exceeding 66% this year, the fund is now exhibiting short-term weakness, registering a 12.7% decline over the past week and a 7.1% drop for the month. This raises a critical question for investors: is this a standard market correction or the start of a more profound trend reversal?

A Closer Look at Performance Metrics

Despite the recent pullback, the fund’s longer-term performance remains robust. Since the start of the year, it has advanced by more than 66%, with its one-year performance standing at approximately 63%. The fund’s substantial $4.1 billion in assets under management and an average daily trading volume of nearly 750,000 shares ensure ample liquidity for investors. With an expense ratio of 0.56%, the fund’s costs are considered reasonable for such a specialized sector. It was recently trading at a slight discount of 0.32% to its net asset value (NAV).

Uranium Market Dynamics

Pressure is evident in the underlying commodity market. The spot price for uranium has retreated to $78.20 per pound, marking a 1.94% decrease over the past month. This decline comes after the nuclear metal recently hit a 14-month high of $84. This price volatility reflects the mixed signals emerging from the political and economic landscape.

Contradicting the price softness, the fundamental and political backdrop for nuclear energy appears strong. At the end of October, the state of Illinois lifted its long-standing moratorium on nuclear plant construction. New York is actively seeking proposals for advanced reactor technologies, and a presidential executive order has set an ambitious goal of quadrupling U.S. nuclear capacity by 2050. Furthermore, demand is being driven by the technology sector, with giants like Microsoft, Google, and Amazon pursuing nuclear power to meet the substantial energy needs of their data centers.

Should investors sell immediately? Or is it worth buying VanEck Uranium+Nuclear Energy ETF?

Portfolio Composition and Sector Exposure

The ETF provides exposure to 28 different securities, with its top ten holdings accounting for a concentrated 54.9% of the fund’s total assets. The leading positions are:

  • Cameco Corp.: 8.18%
  • Constellation Energy Corp.: 7.61%
  • Oklo Inc. Class A: 6.38%
  • BWX Technologies Inc.: 6.07%
  • Centrus Energy Corp.: 5.63%

From a sector perspective, the fund is diversified across the nuclear value chain. The primary allocations are to Energy companies (47.6%), Utilities (32.5%), and Industrials (16.6%).

Future Trajectory for the Nuclear Sector

The central question for investors is whether the ETF can sustain its powerful long-term performance. The core investment thesis for nuclear energy remains intact, supported by global energy security concerns, international decarbonization targets, and burgeoning demand from the tech industry. However, the recent market turbulence serves as a clear reminder that even high-growth, future-oriented markets are not immune to short-term corrections and inherent volatility.

Ad

VanEck Uranium+Nuclear Energy ETF Stock: Buy or Sell?! New VanEck Uranium+Nuclear Energy ETF Analysis from February 7 delivers the answer:

The latest VanEck Uranium+Nuclear Energy ETF figures speak for themselves: Urgent action needed for VanEck Uranium+Nuclear Energy ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

VanEck Uranium+Nuclear Energy ETF: Buy or sell? Read more here...

Tags: VanEck Uranium+Nuclear Energy ETF
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Riley Exploration Permian Stock
Analysis

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

February 7, 2026
Tellurian Stock
Energy & Oil

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026
Next Post
Sunrun Stock

Sunrun Shares Slide as Mixed Quarterly Results Disappoint Investors

Xerox Stock

Xerox Faces Mounting Financial Pressure Following Credit Downgrade

Applovin Stock

AppLovin Shares Surge as AI Technology Drives Record Performance

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com